US20190382393A1 - Bis(benzoxazinyl)phthalimidine and associated curable composition and composite - Google Patents
Bis(benzoxazinyl)phthalimidine and associated curable composition and composite Download PDFInfo
- Publication number
- US20190382393A1 US20190382393A1 US16/376,289 US201916376289A US2019382393A1 US 20190382393 A1 US20190382393 A1 US 20190382393A1 US 201916376289 A US201916376289 A US 201916376289A US 2019382393 A1 US2019382393 A1 US 2019382393A1
- Authority
- US
- United States
- Prior art keywords
- bis
- phthalimidine
- benzoxazinyl
- phenyl
- occurrence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC.CC.CC.[1*]N1C(=O)C2=CC=CC=C2C1(C1=CC2=C(C=C1)OCN([2*])C2)C1=C/C=C2/OCN([2*])C/C2=C\1 Chemical compound CC.CC.CC.[1*]N1C(=O)C2=CC=CC=C2C1(C1=CC2=C(C=C1)OCN([2*])C2)C1=C/C=C2/OCN([2*])C/C2=C\1 0.000 description 10
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/20—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the epoxy compounds used
- C08G59/22—Di-epoxy compounds
- C08G59/26—Di-epoxy compounds heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/0683—Polycondensates containing six-membered rings, condensed with other rings, with nitrogen atoms as the only ring hetero atoms
- C08G73/0688—Polycondensates containing six-membered rings, condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only one nitrogen atom in the ring, e.g. polyquinolines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/16—Nitrogen-containing compounds
- C08K5/34—Heterocyclic compounds having nitrogen in the ring
- C08K5/35—Heterocyclic compounds having nitrogen in the ring having also oxygen in the ring
- C08K5/357—Six-membered rings
Definitions
- Benzoxazines are a class of thermoset materials that are useful in the fabrication of electronic devices and other composites. Benzoxazines can undergo thermal curing with or without a curing catalyst to form polybenzoxazines. Relative to epoxy thermosets, benzoxazines typically cure at lower temperatures and do not require curing catalysts or hardening agents. Cured thermosets derived from benzoxazines also absorb much less moisture than those derived from epoxies. Benzoxazines also demonstrate near-zero shrinkage during curing (which is a significant improvement from epoxy resins), and no volatiles are released during curing reactions.
- Polybenzoxazines offer a low melt viscosity, high glass transition temperature, high thermal stability, good mechanical strength, low dielectric constant and good resistance to burning.
- the cure exotherms for benzoxazines are much lower than those of epoxies, thereby allowing fabrication of thicker sections, longer injection times, and larger parts.
- One embodiment is a bis(benzoxazinyl)phthalimidine having the structure
- R 1 is hydrogen, C 1 -C 6 alkyl, phenyl, or phenyl substituted with up to five substituents independently selected from halogen and C 1 -C 6 alkyl; each occurrence of R 2 is independently selected from the group consisting of unsubstituted or substituted C 1 -C 30 hydrocarbyl; each occurrence of R 3 is independently C 1 -C 6 alkyl; j is 0, 1, 2, 3, or 4; each occurrence of R 4 is independently selected from the group consisting of C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 1 -C 12 alkoxyl; and each occurrence of k is independently 0, 1, 2, or 3.
- Another embodiment is a curable composition comprising the bis(benzoxazinyl)phthalimidine in any of its variations.
- Another embodiment is a composite comprising a reinforcing filler and a curing product of the bis(benzoxazinyl)phthalimidine in any of its variations.
- the FIGURE is a chemical scheme for the synthesis of 2-phenyl-3,3-bis(3-phenyl-3,4-dihydro-2H-benzo[e][1,3]oxazin-6-yl)isoindolin-1-one.
- the present inventors have determined that a bis(benzoxazinyl)phthalimidine compound exhibits a higher melting temperature and higher exotherm onset temperature than a corresponding bis(benzoxazinyl)phenophthalein compound.
- One embodiment is a bis(benzoxazinyl)phthalimidine having the structure
- R 1 is hydrogen, C 1 -C 6 alkyl, phenyl, or phenyl substituted with up to five substituents independently selected from halogen and C 1 -C 6 alkyl; each occurrence of R 2 is independently selected from the group consisting of unsubstituted or substituted C 1 -C 30 hydrocarbyl; each occurrence of R 3 is independently C 1 -C 6 alkyl; j is 0, 1, 2, 3, or 4; each occurrence of R 4 is independently selected from the group consisting of C 1 -C 12 alkyl, C 2 -C 12 alkenyl, and C 1 -C 12 alkoxyl; and each occurrence of k is independently 0, 1, 2, or 3.
- hydrocarbyl refers to a residue that contains only carbon and hydrogen unless it is specifically identified as “substituted hydrocarbyl”.
- the hydrocarbyl residue can be aliphatic or aromatic, straight-chain, cyclic, bicyclic, branched, saturated, or unsaturated. It can also contain combinations of aliphatic, aromatic, straight chain, cyclic, bicyclic, branched, saturated, and unsaturated hydrocarbon moieties. When the hydrocarbyl residue is described as substituted, it can contain heteroatoms in addition to carbon and hydrogen.
- alkyl includes linear, branched, cyclic, and polycyclic alkyl groups, as well as alkyl groups having a combination of at least two types of linear, branched, cyclic, and polycyclic alkyl fragments.
- halogen means fluoro, chloro, bromo, or iodo.
- substituted means including at least one substituent such as a halogen, hydroxyl, amino, thiol, carboxyl, carboxylate, amide, cyano, sulfide, disulfide, nitro, C 1 -C 18 alkyl, C 1 -C 18 alkoxyl, C 6 -C 18 aryl, C 6 -C 18 aryloxyl, C 7 -C 18 alkylaryl, or C 7 -C 18 alkylaryloxyl.
- “Substituted” further means including at least one heteroatom within the carbon framework, as contrasted with pendant to the carbon framework.
- substituted aryl includes pyridyl.
- R 1 is phenyl, or phenyl substituted with 1, 2, 3, 4, or 5 substituents independently selected from halogen and C 1 -C 6 alkyl. In some embodiments, R 1 is phenyl.
- each occurrence of R 2 is independently selected from the group consisting of C 1 -C 12 alkyl (including, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl), anthracenyl, biphenyl, cyclohexenyl, cyclopentenyl, indanyl, naphthyl, and phenyl.
- each occurrence of R 2 is C 1 -C 12 alkyl or phenyl.
- each occurrence of R 2 is phenyl.
- R 1 is phenyl
- each occurrence of R 2 is phenyl.
- j is 0. In some embodiments, each occurrence of k is 0. In some embodiments, j is 0, and each occurrence of k is 0.
- the bis(benzoxazinyl)phthalimidine can be synthesized by reacting a 3,3-bis(4-hydroxyphenyl)phthalimidine substituted in the 2-position with the desired R 1 group with at least two equivalents of paraformaldehyde or other formaldehyde equivalent, and with at least two equivalents of an amine substituted with the desired R 2 group.
- the resulting product bis(benzoxazinyl)phthalimidine can be purified by conventional methods, including chromatography, precipitation, recrystallization, and combinations thereof.
- Another embodiment is a curable composition
- a curable composition comprising the bis(benzoxazinyl)phthalimidine in any of its above-described variations.
- the bis(benzoxazinyl)phthalimidine can be cured in the absence of any curing catalyst or curing agent. So, it is possible for the curable composition to consist of the bis(benzoxazinyl)phthalimidine.
- the curable composition comprises, in addition to the bis(benzoxazinyl)phthalimidine, an epoxy compound.
- the bis(benzoxazinyl)phthalimidine and the epoxy compound can be co-cured without the need for any of the curing agents or curing catalysts typically required by epoxy compounds.
- Epoxy compounds include, for example, aliphatic epoxy resins, cycloaliphatic epoxy resins, aromatic epoxy resins (including bisphenol-A epoxy resins, bisphenol-F epoxy resins, phenol novolac epoxy resins, cresol-novolac epoxy resins, biphenyl epoxy resins, triglycidyl p-aminophenol, tetraglycidyl diamino diphenyl methane, naphthalene epoxy resins, 2-glycidylphenylglycidyl ether, 4-glycidylphenylglycidyl ether, 2-phenyl-3,3-bis(4-glycidyloxyphenyl)phthalimidine, and multi-aromatic resin (MAR-type) epoxy resins), dicyclopentadiene-type (DCPD-type) epoxy resins, and combinations thereof.
- aromatic epoxy resins including bisphenol-A epoxy resins, bisphenol-F epoxy resins, phenol novolac epoxy resins, cresol-
- the epoxy compound is selected from the group consisting of bisphenol-A epoxy resins, bisphenol-F epoxy resins, neopentylglycol epoxy resins, 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexane carboxylate, N,N-diglycidyl-4-glycidyloxyaniline, N,N,N′,N′-tetraglycidyl-4,4′-diaminodiphenylmethane, 2-phenyl-3,3-bis(4-glycidyloxyphenyl)phthalimidine, and combinations thereof.
- the curable composition further comprises, in addition to the bis(benzoxazinyl)phthalimidine, a diglycidyl ether compound having the structure
- R 1 is hydrogen, C 1 -C 6 alkyl, phenyl, or phenyl substituted with up to five substituents independently selected from halogen and C 1 -C 6 alkyl; each occurrence of R 3 is independently C 1 -C 6 alkyl; j is 0, 1, 2, 3, or 4; each occurrence of R 4 is independently selected from the group consisting of C 1 -C 12 alkyl, C 2 -C 12 alkenyl, and C 1 -C 12 alkoxyl; and each occurrence of m is independently 0, 1, 2, 3, or 4.
- R 1 is phenyl, or phenyl substituted with 1, 2, 3, 4, or 5 substituents independently selected from halogen and C 1 -C 6 alkyl. In some embodiments, R 1 is phenyl.
- j is 0. In some embodiments of the diglycidyl ether compound, each occurrence of k is 0. In some embodiments of the diglycidyl ether compound, j is 0, and each occurrence of k is 0.
- the bis(benzoxazinyl)phthalimidine has the structure
- R 1 is phenyl
- each occurrence of R 2 is C 1 -C 12 alkyl or phenyl. In some embodiments, each occurrence of R 2 is phenyl.
- the curable composition comprises the bis(benzoxazinyl)phthalimidine in an amount of 10 to 100 weight percent, based on the total weight of the curable composition.
- the amount of bis(benzoxazinyl)phthalimidine can be 25 to 100 weight percent, or 50 to 100 weight percent, or 75 to 100 weight percent, or 90 to 100 weight percent, or 95 to 100 weight percent.
- the composition can comprise 10 to 90 weight percent of the bis(benzoxazinyl)phthalimidine and 10 to 90 weight percent of the diglycidyl ether compound, based on the total weight of the curable composition.
- the curable composition can comprise 25 to 75 weight percent of the bis(benzoxazinyl)phthalimidine and 25 to 75 weight percent of the diglycidyl ether compound, or 40 to 60 weight percent of the bis(benzoxazinyl)phthalimidine and 40 to 60 weight percent of the diglycidyl ether compound.
- the curable composition can, optionally, further comprise one or more thermoset additives.
- additives include, for example, flame retardants, lubricants, mold release agents, antioxidants, thermal stabilizers, ultraviolet stabilizers, colorants (including pigments and dyes), anti-static agents, and combinations thereof.
- flame retardants flame retardants
- lubricants mold release agents
- antioxidants thermal stabilizers
- ultraviolet stabilizers colorants (including pigments and dyes)
- anti-static agents and combinations thereof.
- additives can be used in a total amount of 1 part per million by weight to 20 weight percent, based on the total weight of the composition. Within this range, the total amount of colorants can be 0.1 to 10 weight percent, or 0.2 to 5 weight percent.
- the curable composition can, optionally, further include a filler.
- Fillers include, for example, silica, boron nitride, boron-silicate, alumina, aluminum diboride, magnesium oxide, wollastonite, calcium sulfate, calcium carbonate, talc, basalt, glass fibers, glass flakes, glass spheres, kaolin, mica, feldspar, nepheline syenite, flue dust, cenospheres, fillite, natural silica sand, quartz, quartzite, perlite, tripoli, diatomaceous earth, silicon carbide, molybdenum sulfide, zinc sulfide, aluminum silicate (mullite), calcium silicate, zirconium silicate, barium titanate, barium ferrite, barium sulfate, particulate and fibrous aluminum, particulate and fibrous bronze, particulate and fibrous zinc, particulate and fibrous copper, particulate and fibr
- the filler is a reinforcing filler.
- Reinforcing fillers include, for example, metal fibers, metallized inorganic fibers, metallized synthetic fibers, glass fibers, graphite fibers, carbon fibers, ceramic fibers, mineral fibers, basalt fibers, polymer fibers having a melting or glass transition temperature at least 100° C. higher than decomposition onset temperature of the bis(benzoxazinyl)phthalimidine (including aramid fibers), and combinations thereof.
- the reinforcing fillers can be in the form of woven fabrics (including plain weave fabrics, satin weave fabrics, and non-crimp fabrics), non-woven fabrics, unidirectional fibers, braided fibers, fiber tow, and fiber ropes.
- the fillers can be used in an amount of 0.5 to 1000 weight parts, based on 100 parts by weight of the bis(benzoxazinyl)phthalimidine. Within this range, the filler amount can be 10 to 500 weight parts, or 20 to 400 weight parts.
- Another embodiment is a composite comprising a reinforcing filler and the curing product of the bis(benzoxazinyl)phthalimidine in any of its above-described variations.
- reinforcing fillers are describe above in the context of the curable composition.
- the reinforcing filler is selected from the group consisting of glass fiber, carbon fiber, and combinations thereof.
- the bis(benzoxazinyl)phthalimidine has the structure
- R 1 is phenyl
- R 2 is phenyl
- the composite can, optionally, further comprise a curing product of an epoxy compound.
- Epoxy compounds are describe above in the context of the curable composition.
- the composite comprises the reinforcing filler in an amount of 0.5 to 1000 weight parts, based on 100 parts by weight of a curing product of the bis(benzoxazinyl)phthalimidine and a curing product of the optional epoxy compound.
- the filler amount can be 10 to 500 weight parts, or 20 to 400 weight parts.
- the invention includes at least the following embodiments.
- R 1 is hydrogen, C 1 -C 6 alkyl, phenyl, or phenyl substituted with up to five substituents independently selected from halogen and C 1 -C 6 alkyl; each occurrence of R 2 is independently selected from the group consisting of unsubstituted or substituted C 1 -C 30 hydrocarbyl; each occurrence of R 3 is independently C 1 -C 6 alkyl; j is 0, 1, 2, 3, or 4; each occurrence of R 4 is independently selected from the group consisting of C 1 -C 12 alkyl, C 2 -C 12 alkenyl, and C 1 -C 12 alkoxyl; and each occurrence of k is independently 0, 1, 2, or 3.
- Aspect 2 The bis(benzoxazinyl)phthalimidine of aspect 1, wherein R 1 is phenyl, or phenyl substituted with 1, 2, 3, 4, or 5 substituents independently selected from halogen and C 1 -C 6 alkyl.
- Aspect 3 The bis(benzoxazinyl)phthalimidine of aspect 1, wherein R 1 is phenyl.
- Aspect 4 The bis(benzoxazinyl)phthalimidine of any one of aspects 1-3, wherein each occurrence of R 2 is independently selected from the group consisting of C 1 -C 12 alkyl (including, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl), anthracenyl, biphenyl, cyclohexenyl, cyclopentenyl, indanyl, naphthyl, and phenyl.
- C 1 -C 12 alkyl including, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl
- anthracenyl biphenyl, cyclohexenyl, cyclopentenyl, indanyl, naphthyl, and phen
- Aspect 5 The bis(benzoxazinyl)phthalimidine of any one of aspects 1-3, wherein each occurrence of R 2 is C 1 -C 12 alkyl or phenyl.
- Aspect 6 The bis(benzoxazinyl)phthalimidine of any one of aspects 1-5, wherein j is 0, and each occurrence of k is 0.
- Aspect 7 The bis(benzoxazinyl)phthalimidine of aspect 1, wherein R 1 is phenyl, each occurrence of R 2 is phenyl, j is 0, and each occurrence of k is 0.
- a curable composition comprising the bis(benzoxazinyl)phthalimidine of any one of aspects 1-7.
- Aspect 9 The curable composition of aspect 8, further comprising an epoxy resin selected from the group consisting of aliphatic epoxy resins, cycloaliphatic epoxy resins, aromatic epoxy resins, dicyclopentadiene-type (DCPD-type) epoxy resins, and combinations thereof.
- an epoxy resin selected from the group consisting of aliphatic epoxy resins, cycloaliphatic epoxy resins, aromatic epoxy resins, dicyclopentadiene-type (DCPD-type) epoxy resins, and combinations thereof.
- Aspect 10 The curable composition of aspect 9, wherein the epoxy resin is selected from the group consisting of bisphenol-A diglycidyl ether, bisphenol-F diglycidyl ether, neopentylglycol diglycidyl ether, 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexane carboxylate, N,N-diglycidyl-4-glycidyloxyaniline, N,N,N′,N′-tetraglycidyl-4,4′-diaminodiphenylmethane, 2-phenyl-3,3-bis(4-glycidyloxyphenyl)phthalimidine, and combinations thereof.
- the epoxy resin is selected from the group consisting of bisphenol-A diglycidyl ether, bisphenol-F diglycidyl ether, neopentylglycol diglycidyl ether, 3,4-epoxycyclohexylmethyl-3,4-ep
- Aspect 11 The curable composition of aspect 9, wherein the epoxy resin is a diglycidyl ether compound having the structure
- R 1 is hydrogen, C 1 -C 6 alkyl, phenyl, or phenyl substituted with up to five substituents independently selected from halogen and C 1 -C 6 alkyl; each occurrence of R 3 is independently C 1 -C 6 alkyl; j is 0, 1, 2, 3, or 4; each occurrence of R 4 is independently selected from the group consisting of C 1 -C 12 alkyl, C 2 -C 12 alkenyl, and C 1 -C 12 alkoxyl; and each occurrence of m is independently 0, 1, 2, 3, or 4.
- Aspect 12 The curable composition of any one of aspects 7-10, comprising the bis(benzoxazinyl)phthalimidine of aspect 7.
- Aspect 13 A composite comprising a reinforcing filler and a curing product of the bis(benzoxazinyl)phthalimidine of any one of aspects 1-7.
- Aspect 14 The composite of aspect 13, comprising a reinforcing filler and a curing product of the bis(benzoxazinyl)phthalimidine of aspect 7.
- the pure product was obtained by washing the silica gel with chloroform and filtering out the silica gel. The filtrate was then precipitated in hexane and dried.
- a proton nuclear magnetic resonance ( 1 H NMR) spectrum confirmed the formation of pure PPPBP-BZ as the product.
- the 1 H NMR spectrum was obtained using a Mercury Plus 400 Megahertz 1 H-NMR spectrometer.
- Phenolphthalein (19.91 grams, 0.0626 mole) was added to a 500 milliliter 3-neck flask equipped with a Dean-Stark apparatus and a condenser. The phenolphthalein was allowed to partially dissolve in 45 milliliters toluene at 80° C. for about 30 minutes. To this solution, paraformaldehyde (12.4 grams, 0.4 mole) was added, followed by aniline (13 milliliters, 0.14 moles) and 15 milliliters of ethanol.
- the reaction was allowed to stir for 24 hours at 85 to 90° C.
- the solution was allowed to cool to room temperature and the solvent was removed under reduced pressure to yield an oil.
- the oil was dispersed in small amount of methylene chloride and precipitated into hexane to yield yellow powder (crude yield 39 grams, 114.7%).
- the crude product was purified using preparatory HPLC in hexane and ethyl acetate solvent. The pure fractions were mixed and concentrated in vacuum to yield a colorless oil which was mixed with methylene chloride and precipitated into hexane to yield a pale off-white solid. 1 H NMR spectrum confirmed the formation of pure Phen-BZ as the product.
- thermosets were prepared by the following method. A small amount of the solid ( ⁇ 60 mg) in an aluminum pan was placed in a Blue M Oven from Thermal Product Solutions and cured at atmospheric pressure according to the curing protocol detailed below in Table 1.
- DSC Differential Scanning calorimetry
- T m values for the bis(benzoxazine) compounds were determined based on the heating portion of this first thermal cycle, and curing occurred in the high temperature portion of the cycle.
- a second thermal cycle was conducted under the same conditions, and the heating portion of this second thermal cycle was used to determine T g values for the cured products of the bis(benzoxazine) compounds.
- TGA Thermal Gravimetric Analysis
Abstract
Description
- This application claims priority from European Patent Application No. 18177776.4 filed on Jun. 14, 2018, which is incorporated by reference herein in its entirety.
- Benzoxazines are a class of thermoset materials that are useful in the fabrication of electronic devices and other composites. Benzoxazines can undergo thermal curing with or without a curing catalyst to form polybenzoxazines. Relative to epoxy thermosets, benzoxazines typically cure at lower temperatures and do not require curing catalysts or hardening agents. Cured thermosets derived from benzoxazines also absorb much less moisture than those derived from epoxies. Benzoxazines also demonstrate near-zero shrinkage during curing (which is a significant improvement from epoxy resins), and no volatiles are released during curing reactions. Polybenzoxazines offer a low melt viscosity, high glass transition temperature, high thermal stability, good mechanical strength, low dielectric constant and good resistance to burning. In addition, the cure exotherms for benzoxazines are much lower than those of epoxies, thereby allowing fabrication of thicker sections, longer injection times, and larger parts.
- Compounds containing two benzoxazine groups (i.e., bis(benzoxazinyl) compounds) are known. See, for example, U.S. Patent Application No. US 2011/0152453 A1 of Tietze et al., which describes bis(benzoxazinyl) derivatives of phenolphthalein. However, there is a desire for bis(benzoxazinyl) compounds exhibiting higher melting temperatures and higher exotherm onset temperatures.
- One embodiment is a bis(benzoxazinyl)phthalimidine having the structure
- wherein R1 is hydrogen, C1-C6 alkyl, phenyl, or phenyl substituted with up to five substituents independently selected from halogen and C1-C6 alkyl; each occurrence of R2 is independently selected from the group consisting of unsubstituted or substituted C1-C30 hydrocarbyl; each occurrence of R3 is independently C1-C6 alkyl; j is 0, 1, 2, 3, or 4; each occurrence of R4 is independently selected from the group consisting of C1-C12 alkyl, C2-C12 alkenyl, C1-C12 alkoxyl; and each occurrence of k is independently 0, 1, 2, or 3.
- Another embodiment is a curable composition comprising the bis(benzoxazinyl)phthalimidine in any of its variations.
- Another embodiment is a composite comprising a reinforcing filler and a curing product of the bis(benzoxazinyl)phthalimidine in any of its variations.
- These and other embodiments are described in detail below.
- The FIGURE is a chemical scheme for the synthesis of 2-phenyl-3,3-bis(3-phenyl-3,4-dihydro-2H-benzo[e][1,3]oxazin-6-yl)isoindolin-1-one.
- The present inventors have determined that a bis(benzoxazinyl)phthalimidine compound exhibits a higher melting temperature and higher exotherm onset temperature than a corresponding bis(benzoxazinyl)phenophthalein compound.
- One embodiment is a bis(benzoxazinyl)phthalimidine having the structure
- wherein R1 is hydrogen, C1-C6 alkyl, phenyl, or phenyl substituted with up to five substituents independently selected from halogen and C1-C6 alkyl; each occurrence of R2 is independently selected from the group consisting of unsubstituted or substituted C1-C30 hydrocarbyl; each occurrence of R3 is independently C1-C6 alkyl; j is 0, 1, 2, 3, or 4; each occurrence of R4 is independently selected from the group consisting of C1-C12 alkyl, C2-C12 alkenyl, and C1-C12 alkoxyl; and each occurrence of k is independently 0, 1, 2, or 3.
- As used herein, the term “hydrocarbyl”, whether used by itself, or as a prefix, suffix, or fragment of another term, refers to a residue that contains only carbon and hydrogen unless it is specifically identified as “substituted hydrocarbyl”. The hydrocarbyl residue can be aliphatic or aromatic, straight-chain, cyclic, bicyclic, branched, saturated, or unsaturated. It can also contain combinations of aliphatic, aromatic, straight chain, cyclic, bicyclic, branched, saturated, and unsaturated hydrocarbon moieties. When the hydrocarbyl residue is described as substituted, it can contain heteroatoms in addition to carbon and hydrogen.
- As used herein, the term “alkyl” includes linear, branched, cyclic, and polycyclic alkyl groups, as well as alkyl groups having a combination of at least two types of linear, branched, cyclic, and polycyclic alkyl fragments.
- As used herein, the term “halogen” means fluoro, chloro, bromo, or iodo.
- When not otherwise expressly defined, the term “substituted” means including at least one substituent such as a halogen, hydroxyl, amino, thiol, carboxyl, carboxylate, amide, cyano, sulfide, disulfide, nitro, C1-C18 alkyl, C1-C18 alkoxyl, C6-C18 aryl, C6-C18 aryloxyl, C7-C18 alkylaryl, or C7-C18 alkylaryloxyl. “Substituted” further means including at least one heteroatom within the carbon framework, as contrasted with pendant to the carbon framework. For example, substituted aryl includes pyridyl.
- In some embodiments of the bis(benzoxazinyl)phthalimidine, R1 is phenyl, or phenyl substituted with 1, 2, 3, 4, or 5 substituents independently selected from halogen and C1-C6 alkyl. In some embodiments, R1 is phenyl.
- In some embodiments of the bis(benzoxazinyl)phthalimidine, each occurrence of R2 is independently selected from the group consisting of C1-C12 alkyl (including, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl), anthracenyl, biphenyl, cyclohexenyl, cyclopentenyl, indanyl, naphthyl, and phenyl. In some embodiments, each occurrence of R2 is C1-C12 alkyl or phenyl. In some embodiments, each occurrence of R2 is phenyl. In some embodiments, R1 is phenyl, and each occurrence of R2 is phenyl.
- In some embodiments, j is 0. In some embodiments, each occurrence of k is 0. In some embodiments, j is 0, and each occurrence of k is 0.
- A representative synthesis of a bis(benzoxazinyl)phthalimidine is provided in the working examples below. In general, the bis(benzoxazinyl)phthalimidine can be synthesized by reacting a 3,3-bis(4-hydroxyphenyl)phthalimidine substituted in the 2-position with the desired R1 group with at least two equivalents of paraformaldehyde or other formaldehyde equivalent, and with at least two equivalents of an amine substituted with the desired R2 group. The resulting product bis(benzoxazinyl)phthalimidine can be purified by conventional methods, including chromatography, precipitation, recrystallization, and combinations thereof.
- Another embodiment is a curable composition comprising the bis(benzoxazinyl)phthalimidine in any of its above-described variations. The bis(benzoxazinyl)phthalimidine can be cured in the absence of any curing catalyst or curing agent. So, it is possible for the curable composition to consist of the bis(benzoxazinyl)phthalimidine.
- In other embodiments, the curable composition comprises, in addition to the bis(benzoxazinyl)phthalimidine, an epoxy compound. The bis(benzoxazinyl)phthalimidine and the epoxy compound can be co-cured without the need for any of the curing agents or curing catalysts typically required by epoxy compounds.
- Epoxy compounds include, for example, aliphatic epoxy resins, cycloaliphatic epoxy resins, aromatic epoxy resins (including bisphenol-A epoxy resins, bisphenol-F epoxy resins, phenol novolac epoxy resins, cresol-novolac epoxy resins, biphenyl epoxy resins, triglycidyl p-aminophenol, tetraglycidyl diamino diphenyl methane, naphthalene epoxy resins, 2-glycidylphenylglycidyl ether, 4-glycidylphenylglycidyl ether, 2-phenyl-3,3-bis(4-glycidyloxyphenyl)phthalimidine, and multi-aromatic resin (MAR-type) epoxy resins), dicyclopentadiene-type (DCPD-type) epoxy resins, and combinations thereof.
- In some embodiments, the epoxy compound is selected from the group consisting of bisphenol-A epoxy resins, bisphenol-F epoxy resins, neopentylglycol epoxy resins, 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexane carboxylate, N,N-diglycidyl-4-glycidyloxyaniline, N,N,N′,N′-tetraglycidyl-4,4′-diaminodiphenylmethane, 2-phenyl-3,3-bis(4-glycidyloxyphenyl)phthalimidine, and combinations thereof.
- In some embodiments, the curable composition further comprises, in addition to the bis(benzoxazinyl)phthalimidine, a diglycidyl ether compound having the structure
- wherein R1 is hydrogen, C1-C6 alkyl, phenyl, or phenyl substituted with up to five substituents independently selected from halogen and C1-C6 alkyl; each occurrence of R3 is independently C1-C6 alkyl; j is 0, 1, 2, 3, or 4; each occurrence of R4 is independently selected from the group consisting of C1-C12 alkyl, C2-C12 alkenyl, and C1-C12 alkoxyl; and each occurrence of m is independently 0, 1, 2, 3, or 4.
- In some embodiments of the diglycidyl ether compound, R1 is phenyl, or phenyl substituted with 1, 2, 3, 4, or 5 substituents independently selected from halogen and C1-C6 alkyl. In some embodiments, R1 is phenyl.
- In some embodiments of the diglycidyl ether compound, j is 0. In some embodiments of the diglycidyl ether compound, each occurrence of k is 0. In some embodiments of the diglycidyl ether compound, j is 0, and each occurrence of k is 0.
- In a very specific embodiment of the curable composition, the bis(benzoxazinyl)phthalimidine has the structure
- wherein R1 is phenyl, and each occurrence of R2 is C1-C12 alkyl or phenyl. In some embodiments, each occurrence of R2 is phenyl.
- The curable composition comprises the bis(benzoxazinyl)phthalimidine in an amount of 10 to 100 weight percent, based on the total weight of the curable composition. Within this range, the amount of bis(benzoxazinyl)phthalimidine can be 25 to 100 weight percent, or 50 to 100 weight percent, or 75 to 100 weight percent, or 90 to 100 weight percent, or 95 to 100 weight percent.
- When the curable composition comprises the bis(benzoxazinyl)phthalimidine and the diglycidyl ether compound, the composition can comprise 10 to 90 weight percent of the bis(benzoxazinyl)phthalimidine and 10 to 90 weight percent of the diglycidyl ether compound, based on the total weight of the curable composition. Within these ranges, the curable composition can comprise 25 to 75 weight percent of the bis(benzoxazinyl)phthalimidine and 25 to 75 weight percent of the diglycidyl ether compound, or 40 to 60 weight percent of the bis(benzoxazinyl)phthalimidine and 40 to 60 weight percent of the diglycidyl ether compound.
- The curable composition can, optionally, further comprise one or more thermoset additives. Such additive include, for example, flame retardants, lubricants, mold release agents, antioxidants, thermal stabilizers, ultraviolet stabilizers, colorants (including pigments and dyes), anti-static agents, and combinations thereof. When present, such additives can be used in a total amount of 1 part per million by weight to 20 weight percent, based on the total weight of the composition. Within this range, the total amount of colorants can be 0.1 to 10 weight percent, or 0.2 to 5 weight percent.
- The curable composition can, optionally, further include a filler. Fillers include, for example, silica, boron nitride, boron-silicate, alumina, aluminum diboride, magnesium oxide, wollastonite, calcium sulfate, calcium carbonate, talc, basalt, glass fibers, glass flakes, glass spheres, kaolin, mica, feldspar, nepheline syenite, flue dust, cenospheres, fillite, natural silica sand, quartz, quartzite, perlite, tripoli, diatomaceous earth, silicon carbide, molybdenum sulfide, zinc sulfide, aluminum silicate (mullite), calcium silicate, zirconium silicate, barium titanate, barium ferrite, barium sulfate, particulate and fibrous aluminum, particulate and fibrous bronze, particulate and fibrous zinc, particulate and fibrous copper, particulate and fibrous nickel, particulate and fibrous steel, particulate and fibrous conductive carbon, polyester fibers, aromatic polyamide fibers, polyimide fibers, poly(phenylene sulfide) fibers, polyether ether ketone fibers, and combinations thereof.
- In some embodiments, the filler is a reinforcing filler. Reinforcing fillers include, for example, metal fibers, metallized inorganic fibers, metallized synthetic fibers, glass fibers, graphite fibers, carbon fibers, ceramic fibers, mineral fibers, basalt fibers, polymer fibers having a melting or glass transition temperature at least 100° C. higher than decomposition onset temperature of the bis(benzoxazinyl)phthalimidine (including aramid fibers), and combinations thereof. It will be understood that the reinforcing fillers can be in the form of woven fabrics (including plain weave fabrics, satin weave fabrics, and non-crimp fabrics), non-woven fabrics, unidirectional fibers, braided fibers, fiber tow, and fiber ropes.
- When present, the fillers can be used in an amount of 0.5 to 1000 weight parts, based on 100 parts by weight of the bis(benzoxazinyl)phthalimidine. Within this range, the filler amount can be 10 to 500 weight parts, or 20 to 400 weight parts.
- Another embodiment is a composite comprising a reinforcing filler and the curing product of the bis(benzoxazinyl)phthalimidine in any of its above-described variations.
- Reinforcing fillers are describe above in the context of the curable composition. In some embodiments, the reinforcing filler is selected from the group consisting of glass fiber, carbon fiber, and combinations thereof.
- In a very specific embodiment of the composite, the bis(benzoxazinyl)phthalimidine has the structure
- wherein R1 is phenyl, and each occurrence of R2 is phenyl.
- In addition to the reinforcing filler and a curing product of the bis(benzoxazinyl)phthalimidine, the composite can, optionally, further comprise a curing product of an epoxy compound. Epoxy compounds are describe above in the context of the curable composition.
- The composite comprises the reinforcing filler in an amount of 0.5 to 1000 weight parts, based on 100 parts by weight of a curing product of the bis(benzoxazinyl)phthalimidine and a curing product of the optional epoxy compound. Within this range, the filler amount can be 10 to 500 weight parts, or 20 to 400 weight parts.
- The invention includes at least the following embodiments.
- Aspect 1: A bis(benzoxazinyl)phthalimidine having the structure
- wherein R1 is hydrogen, C1-C6 alkyl, phenyl, or phenyl substituted with up to five substituents independently selected from halogen and C1-C6 alkyl; each occurrence of R2 is independently selected from the group consisting of unsubstituted or substituted C1-C30 hydrocarbyl; each occurrence of R3 is independently C1-C6 alkyl; j is 0, 1, 2, 3, or 4; each occurrence of R4 is independently selected from the group consisting of C1-C12 alkyl, C2-C12 alkenyl, and C1-C12 alkoxyl; and each occurrence of k is independently 0, 1, 2, or 3.
- Aspect 2: The bis(benzoxazinyl)phthalimidine of aspect 1, wherein R1 is phenyl, or phenyl substituted with 1, 2, 3, 4, or 5 substituents independently selected from halogen and C1-C6 alkyl.
- Aspect 3: The bis(benzoxazinyl)phthalimidine of aspect 1, wherein R1 is phenyl.
- Aspect 4: The bis(benzoxazinyl)phthalimidine of any one of aspects 1-3, wherein each occurrence of R2 is independently selected from the group consisting of C1-C12 alkyl (including, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl), anthracenyl, biphenyl, cyclohexenyl, cyclopentenyl, indanyl, naphthyl, and phenyl.
- Aspect 5: The bis(benzoxazinyl)phthalimidine of any one of aspects 1-3, wherein each occurrence of R2 is C1-C12 alkyl or phenyl.
- Aspect 6: The bis(benzoxazinyl)phthalimidine of any one of aspects 1-5, wherein j is 0, and each occurrence of k is 0.
- Aspect 7: The bis(benzoxazinyl)phthalimidine of aspect 1, wherein R1 is phenyl, each occurrence of R2 is phenyl, j is 0, and each occurrence of k is 0.
- Aspect 8: A curable composition comprising the bis(benzoxazinyl)phthalimidine of any one of aspects 1-7.
- Aspect 9: The curable composition of aspect 8, further comprising an epoxy resin selected from the group consisting of aliphatic epoxy resins, cycloaliphatic epoxy resins, aromatic epoxy resins, dicyclopentadiene-type (DCPD-type) epoxy resins, and combinations thereof.
- Aspect 10: The curable composition of aspect 9, wherein the epoxy resin is selected from the group consisting of bisphenol-A diglycidyl ether, bisphenol-F diglycidyl ether, neopentylglycol diglycidyl ether, 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexane carboxylate, N,N-diglycidyl-4-glycidyloxyaniline, N,N,N′,N′-tetraglycidyl-4,4′-diaminodiphenylmethane, 2-phenyl-3,3-bis(4-glycidyloxyphenyl)phthalimidine, and combinations thereof.
- Aspect 11: The curable composition of aspect 9, wherein the epoxy resin is a diglycidyl ether compound having the structure
- wherein R1 is hydrogen, C1-C6 alkyl, phenyl, or phenyl substituted with up to five substituents independently selected from halogen and C1-C6 alkyl; each occurrence of R3 is independently C1-C6 alkyl; j is 0, 1, 2, 3, or 4; each occurrence of R4 is independently selected from the group consisting of C1-C12 alkyl, C2-C12 alkenyl, and C1-C12 alkoxyl; and each occurrence of m is independently 0, 1, 2, 3, or 4.
- Aspect 12: The curable composition of any one of aspects 7-10, comprising the bis(benzoxazinyl)phthalimidine of aspect 7.
- Aspect 13: A composite comprising a reinforcing filler and a curing product of the bis(benzoxazinyl)phthalimidine of any one of aspects 1-7.
- Aspect 14: The composite of aspect 13, comprising a reinforcing filler and a curing product of the bis(benzoxazinyl)phthalimidine of aspect 7.
- All ranges disclosed herein are inclusive of the endpoints, and the endpoints are independently combinable with each other. Each range disclosed herein constitutes a disclosure of any point or sub-range lying within the disclosed range.
- The invention is further illustrated by the following non-limiting examples.
- Synthesis of 2-Phenyl-3,3-bis(3-phenyl-3,4-dihydro-2H-benzo[e][1,3]oxazin-6-yl)isoindolin-1-one (PPPBP-BZ). The FIGURE is a chemical scheme for the synthesis. 2-Phenyl-3,3-bis(4-hydroxyphenyl)phthalimidine (PPPBP, 25 grams, 0.0636 mole) was added to a 500 milliliter 3-neck flask equipped with a Dean-Stark apparatus and a condenser. The PPPBP was allowed to partially dissolve in 45 milliliters of toluene at 80° C. for about 30 minutes. To this mixture, paraformaldehyde (12.4 grams, 0.4 mole) was added followed by aniline (13 milliliters, 0.1424 mole) and 15 milliliters of ethanol. The reaction mixture was allowed to stir for 24 hours at 85 to 90° C. The solution was allowed to cool to room temperature and the solvent was removed under reduced pressure to yield an oil. The oil was dispersed in a small amount of methylene chloride and precipitated into hexane to yield a white powder (crude yield 33 grams, 82.64%). The crude product was purified using a silica plug (solvent: hexane+ethyl acetate), where PPPBP-BZ was retained in the silica gel. The pure product was obtained by washing the silica gel with chloroform and filtering out the silica gel. The filtrate was then precipitated in hexane and dried. A proton nuclear magnetic resonance (1H NMR) spectrum confirmed the formation of pure PPPBP-BZ as the product. The 1H NMR spectrum was obtained using a Mercury Plus 400 Megahertz 1H-NMR spectrometer.
- Synthesis of 3,3-bis(3-phenyl-3,4-dihydro-2H-benzo[e][1,3]oxazin-6-yl)isobenzofuran-1(3H)-one (Phen-BZ, Phenolphthalein bis(benzoxazine)). The synthesis of phenolphthalein bis(benzoxazine) was performed according to literature reports. See, P. Yang and Y. Gu, Journal of Polymer Research, 2011, volume 18, pages 1725-1733; P. Yang, X. Wang, and Y. Gu, Journal of Polymer Research, 2012, volume 19, page 9901; and R. Tietz, D. Orser, Y. Blyakhman, M. Bryant, and B.-S. Lin, “Benzoxazine Compounds Derivated from Phenolphthalein Having Flame-Retardant Properties and a Process for Their Preparation,” European Patent No., EP 1 797 081 B1, 2005. Phenolphthalein (19.91 grams, 0.0626 mole) was added to a 500 milliliter 3-neck flask equipped with a Dean-Stark apparatus and a condenser. The phenolphthalein was allowed to partially dissolve in 45 milliliters toluene at 80° C. for about 30 minutes. To this solution, paraformaldehyde (12.4 grams, 0.4 mole) was added, followed by aniline (13 milliliters, 0.14 moles) and 15 milliliters of ethanol. The reaction was allowed to stir for 24 hours at 85 to 90° C. The solution was allowed to cool to room temperature and the solvent was removed under reduced pressure to yield an oil. The oil was dispersed in small amount of methylene chloride and precipitated into hexane to yield yellow powder (crude yield 39 grams, 114.7%). The crude product was purified using preparatory HPLC in hexane and ethyl acetate solvent. The pure fractions were mixed and concentrated in vacuum to yield a colorless oil which was mixed with methylene chloride and precipitated into hexane to yield a pale off-white solid. 1H NMR spectrum confirmed the formation of pure Phen-BZ as the product.
- Cured thermosets were prepared by the following method. A small amount of the solid (˜60 mg) in an aluminum pan was placed in a Blue M Oven from Thermal Product Solutions and cured at atmospheric pressure according to the curing protocol detailed below in Table 1.
-
TABLE 1 Step No. Temperature (° C.) Equilibration Time (min) 1 140 60 2 160 60 3 180 60 4 200 30 5 220 30 - Differential Scanning calorimetry (DSC) according to ASTM D3418-15 was used to determine the melting temperatures (Tm) of the bis(benzoxazine) compounds, and the glass transition temperatures (Tg) of the cured products of the bis(benzoxazine) compounds. Testing was performed using a Q1000 differential scanning calorimeter from TA Instruments. In a typical procedure, a polymer sample (10-20 milligrams) was heated from 40° C. to 325° C. at 20° C./minute, held at 325° C. for 1 minute, cooled back to 40° C. at 20° C./minute, then held at 40° C. for 1 minute. Tm values for the bis(benzoxazine) compounds were determined based on the heating portion of this first thermal cycle, and curing occurred in the high temperature portion of the cycle. A second thermal cycle was conducted under the same conditions, and the heating portion of this second thermal cycle was used to determine Tg values for the cured products of the bis(benzoxazine) compounds.
- Thermal Gravimetric Analysis (TGA) was performed with a TA Q800 TGA. The samples were scanned from 40° C. to 800° C. under nitrogen and air with a heating rate of 20° C./minute. This analysis was also used to determine the temperature of peak decomposition (also referred as the onset decomposition temperature), and the char yield at the end of the TGA run.
- The property results in Table 2 show that the bis(benzoxazinyl)phthalimidine exhibits a substantially higher melting temperature and a substantially higher exotherm onset temperature relative to the corresponding bis(benzoxazinyl)phenophthalein.
-
TABLE 2 PPPBP-BZ Phen-BZ Melting temperature (° C.) 139.5 ~95 Onset of Exotherm (° C.) ~210 ~190 Tg of cured material (° C.) 238 235 Onset of decomposition (° C.) N2 349 320 air 383 300 1% weight loss (° C.) N2 203 276 air 76 267 5% weight loss (° C.) N2 350 357 air 369 381 Char yield (%) N2 44.97 59.45 air 0.89 0
Claims (14)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18177776 | 2018-06-14 | ||
EP18177776.4 | 2018-06-14 | ||
EP18177776 | 2018-06-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
US10487077B1 US10487077B1 (en) | 2019-11-26 |
US20190382393A1 true US20190382393A1 (en) | 2019-12-19 |
Family
ID=62636111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/376,289 Active US10487077B1 (en) | 2018-06-14 | 2019-04-05 | Bis(benzoxazinyl)phthalimidine and associated curable composition and composite |
Country Status (2)
Country | Link |
---|---|
US (1) | US10487077B1 (en) |
CN (1) | CN110606845A (en) |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH496021A (en) | 1966-03-10 | 1970-09-15 | Ciba Geigy | Preparation of polyglycidyl ethers |
BE758754A (en) | 1969-11-11 | 1971-04-16 | Bayer Ag | NEW DERIVATIVES OF 3,3-BIS- (NITROARYLOXYARYL) -PHTHALIDES AND PHTHALIMIDINES AND THEIR PREPARATION PROCESS |
JP2648359B2 (en) | 1989-01-23 | 1997-08-27 | 出光興産株式会社 | Polyformal resin, method for producing the same, and binder for charge transporting material |
JPH02283726A (en) | 1989-01-26 | 1990-11-21 | Idemitsu Kosan Co Ltd | Aromatic polyether and its production |
JP2820277B2 (en) | 1989-08-11 | 1998-11-05 | 出光興産株式会社 | Phosphor |
JP3297469B2 (en) | 1992-06-23 | 2002-07-02 | 出光興産株式会社 | Electrophotographic photoreceptor |
US5344910A (en) | 1993-03-23 | 1994-09-06 | General Electric Company | Heat-resistant polycarbonate resins containing 2-alkyl-3,3-bis(p-hydroxyphenyl)phthalimide |
DE69415594T2 (en) | 1993-07-09 | 1999-08-12 | Gen Electric | Siloxane polyester carbonate block polymer compositions and heat resistant polycarbonate |
JP4316959B2 (en) | 2003-08-20 | 2009-08-19 | 出光興産株式会社 | Polycarbonate copolymer, method for producing the same, and optical member |
US7277230B2 (en) | 2004-03-31 | 2007-10-02 | General Electric Company | Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
US7135577B2 (en) | 2004-06-28 | 2006-11-14 | General Electric Company | Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
TWI374137B (en) | 2004-09-28 | 2012-10-11 | Huntsman Adv Mat Switzerland | Organic compounds |
US7408016B2 (en) | 2005-07-07 | 2008-08-05 | Sabic Innovative Plastics Ip B.V. | Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
US7329720B2 (en) | 2005-11-29 | 2008-02-12 | General Electric Company | Methods for increasing the mean particle size of 2-hydrocarbyl-3,3-bis(hydroxyaryl)phthalimidines |
US7348439B2 (en) | 2005-11-29 | 2008-03-25 | General Electric Company | 2-aryl-3-(aminoaryl)-3-(hydroxyaryl)phthalimidine compounds and methods for making them |
US8487065B2 (en) | 2005-11-30 | 2013-07-16 | Sabic Innovative Plastics Ip B.V. | Copolycarbonate-polyesters, methods of manufacture, and uses thereof |
US7354986B2 (en) | 2005-11-30 | 2008-04-08 | General Electric Company | High glass transition temperature copolycarbonates, methods of manufacture, and uses thereof |
US7495066B2 (en) | 2005-11-30 | 2009-02-24 | Sabic Innovative Plastics Ip B.V. | Copolycarbonate-polyesters, methods of manufacture, and uses thereof |
US7563817B2 (en) | 2005-12-14 | 2009-07-21 | Sabic Innovative Plastics Ip Bv | Purified 2-aryl-3,3-bis(hydroxyaryl)phthalimidines |
US7491788B1 (en) | 2006-05-19 | 2009-02-17 | Sabic Innovative Plastics Ip B.V. | High heat polycarbonate compositions, methods for the preparation thereof, and articles derived therefrom |
US20080161507A1 (en) | 2006-12-28 | 2008-07-03 | Shreyas Chakravarti | Polyester-polycarbonate blends |
US7884220B2 (en) | 2007-03-19 | 2011-02-08 | General Electric Company | Process for purifying PPPBP |
US7514524B2 (en) | 2007-03-30 | 2009-04-07 | Sabic Innovative Plastics Ip B.V. | Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
US7592464B2 (en) | 2007-03-30 | 2009-09-22 | Sabic Innovative Plastics Ip Bv | Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
US7642315B2 (en) | 2007-06-15 | 2010-01-05 | Sabic Innovative Plastics Ip B.V. | Polycarbonate-poly(alkylene oxide) copolymer compositions and articles formed therefrom |
US7649073B2 (en) | 2007-06-15 | 2010-01-19 | Sabic Innovative Plastics Ip B.V. | Polycarbonate-poly(alkylene oxide) copolymer compositions and articles formed therefrom |
US7842379B2 (en) | 2007-07-05 | 2010-11-30 | Sabic Innovative Plastics Ip B.V. | Polymeric foams with nanocellular morphology and methods for making them |
US9062196B2 (en) | 2007-09-28 | 2015-06-23 | Sabic Global Technologies B.V. | High heat polycarbonates, methods of making, and articles formed therefrom |
US8022166B2 (en) | 2008-06-23 | 2011-09-20 | Sabic Innovative Plastics Ip B.V. | Polycarbonate compositions |
US7935777B2 (en) | 2008-06-23 | 2011-05-03 | Sabic Innovative Plastics Ip B.V. | Polycarbonate compositions |
US7915430B2 (en) | 2008-09-29 | 2011-03-29 | Sabic Innovative Plastics Ip B.V. | Catalytic method for producing phenolphthalein compounds |
US7838689B2 (en) | 2008-09-29 | 2010-11-23 | Sabic Innovative Plastics Ip B.V. | Method for producing phenolphthalein compound using ionic liquid catalyst composition |
US7868190B2 (en) | 2008-09-29 | 2011-01-11 | Sabic Innovative Plastics Ip B.V. | Method for producing phenolphthalein using a heteropolyacid catalyst |
US8247523B2 (en) | 2008-12-12 | 2012-08-21 | Sabic Innovative Plastics Ip B.V. | Methods for producing and purifying 2-aryl-3,3-bis(4-hydroxyaryl)phthalimidine compounds, the purified monomers, and polymers derived therefrom |
US8064140B2 (en) | 2008-12-31 | 2011-11-22 | Sabic Innovative Plastics Ip B.V. | Transparent articles prepared from thermoplastic compositions having low birefringence |
US7999037B2 (en) | 2008-12-31 | 2011-08-16 | Sabic Innovative Plastics Ip B.V. | Polycarbonate compositions |
DE102009023940A1 (en) | 2009-06-04 | 2010-12-09 | Bayer Materialscience Ag | Process for the production of polycarbonate |
JP2013508517A (en) * | 2009-10-27 | 2013-03-07 | ヘンケル・アクチェンゲゼルシャフト・ウント・コムパニー・コマンディットゲゼルシャフト・アウフ・アクチェン | Benzoxazine-containing composition |
US8779162B2 (en) | 2010-01-20 | 2014-07-15 | Mitsubishi Gas Chemical Company, Inc. | Cyanate ester compounds and cured products thereof |
US9115283B2 (en) | 2011-03-31 | 2015-08-25 | Sabic Global Technologies B.V. | Heat resistant clear polycarbonate-polysiloxane compounds |
US8525191B2 (en) | 2011-04-01 | 2013-09-03 | Sabic Innovative Plastics Ip B.V. | Optoelectronic devices and coatings therefore |
JP5687120B2 (en) | 2011-04-20 | 2015-03-18 | ユニチカ株式会社 | Polyarylate resin |
JP5805982B2 (en) | 2011-04-20 | 2015-11-10 | ユニチカ株式会社 | Polyarylate resin film and gas separation membrane |
WO2012155116A1 (en) | 2011-05-12 | 2012-11-15 | Sabic Innovative Plastics Ip B.V. | Amorphous polycarbonate films for capacitors, methods of manufacture, and articles manufactured therefrom |
US8669315B2 (en) | 2011-08-22 | 2014-03-11 | Sabic Innovative Plastics Ip B.V. | Polycarbonate compositions and methods for the manufacture and use thereof |
US9441106B2 (en) | 2011-11-11 | 2016-09-13 | Sabic Global Technologies B.V. | Composition, multilayer sheets made therefrom, and methods for making and using the same |
EP2810309A1 (en) | 2012-02-03 | 2014-12-10 | SABIC Innovative Plastics IP B.V. | Light emitting diode device and method for production thereof containing conversion material chemistry |
GB201205574D0 (en) | 2012-03-29 | 2012-05-16 | Cytec Tech Corp | Benzoxazines and compositions containing the same |
US9127155B2 (en) | 2012-04-11 | 2015-09-08 | Sabic Global Technologies B.V. | Phosphorus free flame retardant composition |
US9580595B2 (en) | 2012-05-16 | 2017-02-28 | Sabic Global Technologies B.V. | Compositions and articles of manufacture containing branched polycarbonate |
JP6240069B2 (en) | 2012-06-07 | 2017-11-29 | 日本化薬株式会社 | Epoxy resin composition, cured product thereof, and curable resin composition |
WO2014031730A1 (en) | 2012-08-21 | 2014-02-27 | Sabic Innovative Plastics Ip B.V. | Transparent plastic article |
US8779040B2 (en) | 2012-10-16 | 2014-07-15 | Sabic Global Technologies B.V. | High-heat polycarbonate blends that are halogen-free and flame retardant |
EP2730618B1 (en) | 2012-11-07 | 2016-10-12 | SABIC Global Technologies B.V. | Process for producing polycarbonate compositions |
US9328240B2 (en) | 2012-12-21 | 2016-05-03 | Sabic Global Technologies B.V. | Polycarbonate compositions, articles formed therefrom, and methods of manufacture thereof |
US9127119B2 (en) | 2013-01-11 | 2015-09-08 | Sabic Global Technologies B.V. | Polycarbonate compositions having improved thermal dimensional stability and high refractive index |
JP6239599B2 (en) | 2013-04-25 | 2017-11-29 | 日本化薬株式会社 | Phenol resin, epoxy resin composition containing the phenol resin, and cured product thereof |
US9266541B2 (en) | 2013-05-01 | 2016-02-23 | Sabic Global Technologies B.V. | Interior train components having low smoke and low heat release, and methods of their manufacture |
US9553244B2 (en) | 2013-05-16 | 2017-01-24 | Sabic Global Technologies B.V. | Branched polycarbonate compositions having conversion material chemistry and articles thereof |
KR102083640B1 (en) | 2013-07-25 | 2020-03-02 | 사빅 글로벌 테크놀러지스 비.브이. | Thermal enhancement of the purification process for interfacial polycarbonate and copolymer polycarbonates |
KR101748685B1 (en) | 2013-07-25 | 2017-06-19 | 사빅 글로벌 테크놀러지스 비.브이. | Process for the purification of polycarbonate |
JP6366590B2 (en) | 2013-09-10 | 2018-08-01 | 日本化薬株式会社 | Epoxy resin mixture, epoxy resin composition, cured product, and semiconductor device |
US9718918B2 (en) | 2013-09-30 | 2017-08-01 | Sabic Global Technologies B.V. | Process to prepare high heat polycarbonates |
WO2015064607A1 (en) | 2013-10-31 | 2015-05-07 | 日本化薬株式会社 | Phenolic resin, epoxy resin composition containing said phenolic resin, and cured product thereof |
DE102013224774A1 (en) | 2013-12-03 | 2015-06-03 | Tesa Se | Multi-layered product |
CN105916842A (en) * | 2014-01-14 | 2016-08-31 | 沙特基础工业全球技术有限公司 | Methods of manufacture of 2-hydrocarbyl-3,3-bis(hydroxyaryl)phthalimidines |
US9951217B2 (en) | 2014-01-30 | 2018-04-24 | Sabic Global Technologies B.V. | Copolymer of a bisphenol diglycidyl ether and a phenolphthalene and/or a phenolphthalimidine, method for the preparation thereof, article comprising the copolymer, and compositions comprising the copolymer |
CN106232719B (en) | 2014-04-15 | 2020-05-29 | 沙特基础工业全球技术有限公司 | Highly heat-resistant polycarbonate compositions |
CN106164175A (en) | 2014-04-15 | 2016-11-23 | 沙特基础工业全球技术有限公司 | High heat polycarbonate compositions |
CN106232718A (en) | 2014-04-15 | 2016-12-14 | 沙特基础工业全球技术有限公司 | High heat polycarbonate compositions |
US10370534B2 (en) | 2014-04-15 | 2019-08-06 | Sabic Global Technologies B.V. | High heat polycarbonate compositions |
WO2015160965A1 (en) | 2014-04-15 | 2015-10-22 | Sabic Global Technologies B.V. | High heat polycarbonate compositions |
US20170037243A1 (en) | 2014-04-15 | 2017-02-09 | Sabic Global Technologies B.V. | High heat polycarbonate compositions |
WO2015162564A1 (en) | 2014-04-23 | 2015-10-29 | Sabic Global Technologies B.V. | Methods for purifying 2-aryl-3,3-bis(hydroxyaryl)phthalimidines |
CN106661317A (en) | 2014-04-30 | 2017-05-10 | 沙特基础全球技术有限公司 | Polycarbonate composition |
CN106457782B (en) | 2014-06-16 | 2019-12-10 | 沙特基础工业全球技术有限公司 | Method for additive manufacturing using thermoplastic material having a selected melt index |
EP3169720B1 (en) | 2014-07-17 | 2018-12-12 | SABIC Global Technologies B.V. | High flow, high heat polycarbonate compositions |
JP6395505B2 (en) | 2014-08-22 | 2018-09-26 | 日本化薬株式会社 | Epoxy (meth) acrylate compound, resin composition containing the same, and cured product thereof |
KR101709695B1 (en) | 2014-08-25 | 2017-02-24 | 삼성에스디아이 주식회사 | Heat-resistant, nonflammable, coated separator and battery |
CN106604947B (en) | 2014-08-26 | 2019-08-06 | 日本化药株式会社 | Reactive polyester compound, the active energy ray-curable resin composition using the compound |
WO2016063154A1 (en) | 2014-10-22 | 2016-04-28 | Sabic Global Technologies B.V. | Polycarbonate/polyester composition and article prepared therefrom |
EP3227374B1 (en) | 2014-12-01 | 2022-06-01 | Covestro Intellectual Property GmbH & Co. KG | Copolycarbonate compounds with improved rheological and optical properties containing diglycerolester |
EP3227387B1 (en) | 2014-12-04 | 2020-03-11 | Covestro Deutschland AG | Copolycarbonate compounds with improved processability containing pe waxes |
CA2977536C (en) * | 2015-03-04 | 2023-10-10 | Huntsman Advanced Materials Americas Llc | Benzoxazine low temperature curable composition |
US20180009935A1 (en) * | 2015-03-18 | 2018-01-11 | Mitsubishi Gas Chemical Company, Inc. | Resin composition, prepreg, metal foil-clad laminate, resin sheet, and printed wiring board |
WO2016176194A1 (en) | 2015-04-27 | 2016-11-03 | Sabic Global Technologies B.V. | Bisphenols and polycarbbonates and the methods of making thereof |
KR20170001987A (en) | 2015-06-29 | 2017-01-06 | 삼성에스디아이 주식회사 | Heat-resistant separator and electrochemical battery |
US10640617B2 (en) | 2015-06-30 | 2020-05-05 | Sabic Global Technologies B.V. | Method of preparing a polymer dispersion and polymer dispersions prepared thereby |
US20180215915A1 (en) | 2015-07-06 | 2018-08-02 | Covestro Deutschland Ag | Galvanized component with high heat distortion resistance |
EP3325533B1 (en) * | 2015-07-23 | 2023-09-13 | Huntsman Advanced Materials Americas LLC | Curable benzoxazine compositions |
JP6789284B2 (en) | 2015-08-26 | 2020-11-25 | サビック グローバル テクノロジーズ ベスローテン フェンノートシャップ | Method for producing crystalline polycarbonate powder |
JP2017071706A (en) | 2015-10-08 | 2017-04-13 | 日本化薬株式会社 | Epoxy resin composition, curable resin composition and cured product thereof |
EP3368608A1 (en) | 2015-10-30 | 2018-09-05 | SABIC Global Technologies B.V. | High impact polyaryletherketone - polycarbonate blends |
KR101904082B1 (en) | 2016-01-20 | 2018-11-14 | 주식회사 삼양사 | Polyester-polycarbonate copolymer and method for preparing the same |
JP6061234B1 (en) | 2016-03-11 | 2017-01-18 | 山栄化学株式会社 | Alkali development type solder resist ink, printed wiring board processing method and wiring board |
WO2017178548A1 (en) * | 2016-04-13 | 2017-10-19 | Henkel Ag & Co. Kgaa | Benzoxazine based copolymer aerogels |
US20190119447A1 (en) | 2016-04-28 | 2019-04-25 | Jxtg Nippon Oil & Energy Corporation | Composition for curable resin, and cured product thereof |
CN106478488A (en) | 2016-10-10 | 2017-03-08 | 陕西省石油化工研究设计院 | One kind comprises cyclic amine groups phenolphthalein monomer and preparation method thereof |
-
2019
- 2019-04-05 US US16/376,289 patent/US10487077B1/en active Active
- 2019-05-13 CN CN201910395537.5A patent/CN110606845A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US10487077B1 (en) | 2019-11-26 |
CN110606845A (en) | 2019-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Spontón et al. | Development of a DOPO-containing benzoxazine and its high-performance flame retardant copolybenzoxazines | |
US5973144A (en) | High char yield benzoxazines | |
US9416271B2 (en) | Halogen free benzoxazine based curable compositions for high Tg applications | |
EP3299355B1 (en) | Phthalonitrile compound | |
Hsuan Lin et al. | Synthesis of a benzoxazine with precisely two phenolic OH linkages and the properties of its high‐performance copolymers | |
Chang et al. | Facile, one‐pot synthesis of aromatic diamine‐based benzoxazines and their advantages over diamines as epoxy hardeners | |
Yang et al. | Synthesis of a novel benzoxazine‐containing benzoxazole structure and its high performance thermoset | |
JP6550136B2 (en) | Trifunctional benzoxazines and their use in curable resin compositions and composites | |
Xie et al. | Improving thermal and flame‐retardant properties of epoxy resins by a new imine linkage phosphorous‐containing curing agent | |
Sponton et al. | Studies on thermal and flame retardant behaviour of mixtures of bis (m-aminophenyl) methylphosphine oxide based benzoxazine and glycidylether or benzoxazine of Bisphenol A | |
US10487077B1 (en) | Bis(benzoxazinyl)phthalimidine and associated curable composition and composite | |
US6160079A (en) | Activated arylamine-based polybenzoxazines | |
KR101579387B1 (en) | Benzoxazine intermediate and preparation method thereof | |
CN103896867A (en) | N-full-aromatic hydrocarbon diamine-bisphenol tetrafunctional fluorenyl benzoxazine and preparation method thereof | |
CN103936765A (en) | N-full aromatic hydrocarbyl bisphenol-diamine tetrafunctional fluorene-based benzoxazine and preparation method thereof | |
US4959443A (en) | Thermosetting resin composition from bis maleimide and aromatic amine resin | |
Ren et al. | High-performance naphthalenediamine-based polybenzoxazine and its cured epoxy resin | |
CN108863973B (en) | Novel amide type benzoxazine resin and one-step preparation method thereof | |
CN111819221B (en) | Phthalonitrile-based resins with improved impact strength | |
EP3549972B1 (en) | Polymerizable composition | |
WO2022163552A1 (en) | Novel benzoxazine compound, resin raw material composition containing same, curable resin composition, and cured product thereof | |
KR20200036608A (en) | A phthalonitrile-based curable resin composition having excellent heat resistance and a prepolymer thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
AS | Assignment |
Owner name: SABIC GLOBAL TECHNOLOGIES B.V., NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SISTA, PRAKASH;REEL/FRAME:049355/0021 Effective date: 20180614 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: SHPP GLOBAL TECHNOLOGIES B.V., NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SABIC GLOBAL TECHNOLOGIES B.V.;REEL/FRAME:054528/0467 Effective date: 20201101 |
|
AS | Assignment |
Owner name: SHPP GLOBAL TECHNOLOGIES B.V., NETHERLANDS Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVE THE APPLICATION NUMBER 15039474 PREVIOUSLY RECORDED AT REEL: 054528 FRAME: 0467. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:SABIC GLOBAL TECHNOLOGIES B.V.;REEL/FRAME:057453/0680 Effective date: 20201101 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |